Institut De Recherches Internationales Servier

This early-phase study tested a new drug (S095029) alone and with another drug (Sym021) in 41 adults with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and see if the drugs could shrink tumors. The planned expansion to test…

This study was designed to test a new drug (S095033) combined with a standard chemotherapy (paclitaxel) in people with advanced or metastatic esophageal squamous cell carcinoma. The goal was to see if the combination was safe and could shrink tumors. However, the trial was withdr…